Scaffold hopping in drug discovery using inductive logic programming

Journal of Chemical Information and Modeling

Volumn 48, Issue 5, 2008, Pages 949-957

  Tsunoyama, Kazuhisa ^a,b   Amini, Ata ^a,c   Sternberg, Michael J E ^a   Muggleton, Stephen H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ASTELLAS PHARMA INC   (Japan)

^c Equinox Pharma Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; COMPUTER CIRCUITS; SCAFFOLDS;

ACTIVE COMPOUNDS; ALTERNATIVE STRUCTURE; CHEMOINFORMATICS; INACTIVE COMPOUNDS; PHARMACEUTICAL COMPANY; RANDOM SELECTION; SPATIAL RELATIONSHIPS; TARGETS OF INTEREST;

INDUCTIVE LOGIC PROGRAMMING (ILP);

ARTICLE; ARTIFICIAL INTELLIGENCE; BIOLOGY; DRUG DESIGN; METHODOLOGY;

ARTIFICIAL INTELLIGENCE; COMPUTATIONAL BIOLOGY; DRUG DESIGN;

EID: 45749130703     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci700418f     Document Type: Article

References (35)

1. Schneider, G.; Neidhart, W.; Giller, T.; Schmid, G. "Scaffold- Hopping" by Topological Pharmacophore Search: a Contribution to Virtual Screening. Angew. Chem., Int. Ed. Engl. 1999, 38, 2894-2896.
2. Brown, N.; Jacoby, E. On Scaffolds and Hopping in Medicinal Chemistry. Mini. Rev. Med. Chem. 2006, 6, 1217-1229.
3. Muggleton, S. H. Inductive Logic Programming. New Generat. Comput. 1991, 8, 295-318.
4. Austin, C. P.; Brady, L. S.; Insel, T. R.; Collins, F. S. NIH Molecular Libraries Initiative. Science 2004, 306, 1138-1139.
5. Dove, A. Screening for Content - The Evolution of High Throughput. Nat. Biotechnol 2003, 21, 859-864.
6. Malo, N.; Hanley, J. A.; Cerquozzi, S.; Pelletier, J.; Nadon, R. Statistical Practice in High-Throughput Screening Data Analysis. Nat. Biotechnol. 2006, 24, 167-175.
7. Lipinski, C.; Hopkins, A. Navigating chemical space for biology and medicine. Nature 2004, 432, 855-861.
8. Stahura, F. L.; Bajorath, J. Virtual screening methods that complement HTS. Comb. Chem. High Throughput Screen. 2004, 7, 259-269.
9. Bajorath, J. Integration of virtual and high-throughput screening. Nat. Rev. Drug Discov. 2002, 1, 882-894.
10. Engels, M. F.; Venkatarangan, P. Smart screening: approaches to efficient HTS. Curr. Opin. Drug Discov. Dev. 2001, 4, 275-283.
11. Willett, P.; Barnard, J. M.; Downs, G. M. Chemical Similarity Searching. J. Chem. Inf. Comput. Sci. 1998, 38, 983-996.
12. Sheridan, R. P.; Kearsley, S. K. Why Do We Need So Many Chemical Similarity Search Methods. Drug Discov. Today 2002, 7, 903-911.
13. Renner, S.; Schneider, G. Scaffold-Hopping Potential of Ligand-Based Similarity Concepts. ChemMedChem 2006, 1, 181-185.
14. Naerum, L.; Norskov-Lauritsen, L.; Olesen, P. H. Scaffold Hopping and Optimization towards Libraries of Glycogen Synthase Kinase-3 Inhibitors. Bioorg. Med. Chem. Lett. 2002, 12, 1525-1528.
15. Franke, L.; Schwarz, O.; Muller-Kuhrt, L.; Hoernig, C.; Fischer, L.; George, S.; Tanrikulu, Y.; Schneider, P.; Werz, O.; Steinhilber, D.; Schneider, G. Identification of Natural-Product-Derived Inhibitors of 5-Lipoxygenase Activity by Ligand-Based Virtual Screening. J. Med. Chem. 2007, 50, 2640-2646.
16. King, R. D.; Whelan, K. E.; Jones, F. M.; Reiser, P. G.; Bryant, C. H.; Muggleton, S. H.; Kell, D. B.; Oliver, S. G. Functional Genomic Hypothesis Generation and Experimentation by a Robot Scientist. Nature 2004, 427, 247-252.
17. King, R. D.; Muggleton, S. H.; Srinivasan, A.; Sternberg, M. J. Structure-Activity Relationships Derived by Machine Learning: the Use of Atoms and Their Bond Connectivities to Predict Mutagenicity by Inductive Logic Programming. Proc. Natl. Acad. Sci. USA 1996, 93, 438-442.
18. Sternberg, M. J.; Muggleton, S. H. Structure Activity Relationships (SAR) and Pharmacophore Discovery Using Inductive Logic Programming (ilp). QSAR Comb. Sci. 2003, 22, 527-532.
19. Vapnik, V. Methods of Pattern Recognition. In The Nature of Statistical Learning Theory, 2nd ed.; Springer: New York, 1995; pp 123-169.
20. Amini, A.; Muggleton, S. H.; Lodhi, H.; Sternberg, M. J. A Novel Logic-Based Approach for Quantitative Toxicology Prediction. J. Chem. Inf. Model. 2007, 47, 998-1006.
21. Cannon, E. D.; Amini, A.; Bender, A.; Sternberg, M. J.; Muggleton, S. H.; Glen, R.; Mitchell, J. Support Vector Inductive Logic Programming Outperforms the Naive Bayes Classifier and Inductive Logic Programming for the Classification of Bioactive Chemical Compounds. J. Comput.-Aided Mol. Des. 2007, 21, 269-280.
22. PubChem. http://pubchem.ncbi.nlm.nih.gov (accessed June 2006).
23. The Open Babel Package, version 2.0.2. http://openbabel.sourceforge.net/ (accessed Jul 3, 2006).
24. Flinger, M. A.; Verducci, J. S.; Blower, P. E. A Modification of the Jaccard-Tanimoto Similarity Index for Diverse Selection of Chemical Compounds Using Binary Strings. Technometrics 2002, 44, 110-119.
25. Butina, D. Unsupervised Data Base Clustering Based on Daylight's Fingerprint and Tanimoto Similarity: A Fast and Automated Way To Cluster Small and Large Data Sets. J. Chem. Inf. Comput. Sci. 1999, 39, 747-750.
26. Muggleton, S. H. Inverse Entailment and Progol. New Generat. Comput. 1995, 13, 245-286.
27. Muggleton, S. H.; Bryant, C. H. Theory Completion Using Inverse Entailment. In Proceedings of the 10th International Conference on Inductive Logic Programming (ILP-00); Cussens, J., Frisch, A. M., Eds.; Springer-Verlag: Berlin, 2000; pp 130-146.
28. Pearlman, R. S. Concord User's Manual; Tripos, Inc.: St Louis, MO, 2000.
29. Fechner, U.; Franke, L.; Renner, S.; Schneider, P.; Schneider, G. Comparison of Correlation Vector Methods for Ligand-Based Similarity Searching. J. Comput.-Aided. Mol. Des. 2003, 17, 687-698.
30. Renner, S.; Schwab, C. H.; Gasteiger, J.; Schneider, G. Impact of Conformational Flexibility on Three-Dimensional Similarity Searching Using Correlation Vectors. J. Chem. Inf. Model. 2006, 46, 2324-2332.
31. Renner, S.; Ludwig, V.; Boden, O.; Scheffer, U.; Gobel, M.; Schneider, G. New Inhibitors of the Tat-TAR RNA Interaction Found with a "Fuzzy" Pharmacophore Model. ChemBioChem 2005, 6, 1119-1125.
32. Renner, S.; Noeske, T.; Parsons, C. G.; Schneider, P.; Weil, T.; Schneider, G. New Allosteric Modulators of Metabotropic Glutamate Receptor 5 (mGluR5) Found by Ligand-Based Virtual Screening. ChemBioChem 2005, 6, 620-625.
33. MOE (Molecular Operating Environment); Chemical Computing Group Inc.: Montreal, Quebec, Canada, 2006.
34. Vogt, A.; Cooley, K. A.; Brisson, M.; Tarpley, M. G.; Wipf, P.; Lazo, J. S. Cell-active dual specificity phosphatase inhibitors identified by high-content screening. Chem. Biol. 2003, 10, 733-742.
35. Perola, E.; Charifson, P. S. Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. J. Med. Chem. 2004, 47, 2499-2510.